Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease

Area of Science:

• Nephrology
• Public Health
• Health Economics

Background:

• Chronic kidney disease (CKD) presents a growing global health challenge.
• Current guidelines recommend specialized nephrologist care for advanced CKD (stage 4+) and primary care for earlier stages.
• Effective management of CKD is crucial to prevent progression to end-stage renal disease (ESRD).

Purpose of the Study:

• To highlight the importance of early CKD detection and timely nephrologist referral.
• To analyze the cost-effectiveness and quality of life associated with different kidney failure therapies.
• To emphasize the role of risk prediction in optimizing clinical planning and resource allocation for CKD.

Main Methods:

• Review of current clinical guidelines for CKD management.
• Comparative analysis of costs and quality of life for kidney failure treatment options.
• Discussion of the impact of early detection and risk prediction strategies.

Main Results:

• Early nephrologist referral improves management of advanced CKD.
• Kidney transplantation offers the best value, followed by peritoneal dialysis, home hemodialysis, and facility-based hemodialysis.
• Accurate risk prediction can enhance clinical planning and resource allocation.

Conclusions:

• Timely intervention and appropriate care setting (nephrology vs. primary care) are vital for CKD patients.
• Understanding the economic and quality-of-life implications of different ESRD treatments is essential for patient-centered care.
• Proactive strategies, including early detection and risk prediction, are crucial for improving CKD outcomes and managing healthcare resources effectively.